Back to Search Start Over

Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis

Authors :
Patricia Ruiz-Limon
Rafaela Ortega-Castro
Nuria Barbarroja
Carlos Perez-Sanchez
Christophe Jamin
Alejandra Maria Patiño-Trives
Maria Luque-Tevar
Alejandro Ibáñez-Costa
Laura Perez-Sanchez
Iván Arias de la Rosa
MaCarmen Abalos-Aguilera
Yolanda Jimenez-Gomez
Jerusalem Calvo-Gutierrez
Pilar Font
Alejandro Escudero-Contreras
Marta E. Alarcon-Riquelme
Eduardo Collantes-Estevez
Chary López-Pedrera
the PRECISESADS Clinical Consortium and Flow Cytometry Study Group
C Marañón
L Le Lann
N Varela
B Muchmore
A Dufour
Alvarez
C Carlo Montserrat Chizzolini
E, NB De Langhe
CL-P
V Gerl
A De Groof
J Ducreux
E Trombetta
T Li
D Alvarez-Errico
S Rao
JO Pers
L Beretta
R AguilarQuesada
MA Aguirre-Zamorano
JL Callejas Rubio
MC Castro-Villegas
R Cervera
C Chizzolini
E Collantes
D Cornec
E De Langhe
V Devauchelle-Pensec
AE-C
G Espinosa
MC Fernández Roldán
T Gomes Anjos
F Hiepe
I Jiménez Moleón
S Jousse-Joulin
B Lauwerys
A López-Berrio
R Lories
J Marovac
PL Meroni
B Miranda
H Navarro-Linares
R Ortega-Castro
N Ortego
E Ramón Garrido
E Raya
R Ríos Fernández
I Rodríguez-Pintó
A Saraux
Source :
Frontiers in Immunology, Vol 10 (2019)
Publication Year :
2019
Publisher :
Frontiers Media S.A., 2019.

Abstract

Objectives: This study, developed within the Innovative Medicines Initiative Joint Undertaking project PRECISESADS framework, aimed at functionally characterize the monocyte subsets in RA patients, and analyze their involvement in the increased CV risk associated with RA.Methods: The frequencies of monocyte subpopulations in the peripheral blood of 140 RA patients and 145 healthy donors (HDs) included in the PRECISESADS study were determined by flow cytometry. A second cohort of 50 RA patients and 30 HDs was included, of which CD14+ and CD16+ monocyte subpopulations were isolated using immuno-magnetic selection. Their transcriptomic profiles (mRNA and microRNA), proinflammatory patterns and activated pathways were evaluated and related to clinical features and CV risk. Mechanistic in vitro analyses were further performed.Results: CD14++CD16+ intermediate monocytes were extended in both cohorts of RA patients. Their increased frequency was associated with the positivity for autoantibodies, disease duration, inflammation, endothelial dysfunction and the presence of atheroma plaques, as well as with the CV risk score. CD14+ and CD16+ monocyte subsets showed distinctive and specific mRNA and microRNA profiles, along with specific intracellular signaling activation, indicating different functionalities. Moreover, that specific molecular profiles were interrelated and associated to atherosclerosis development and increased CV risk in RA patients. In vitro, RA serum promoted differentiation of CD14+CD16− to CD14++CD16+ monocytes. Co-culture with RA-isolated monocyte subsets induced differential activation of endothelial cells.Conclusions: Our overall data suggest that the generation of inflammatory monocytes is associated to the autoimmune/inflammatory response that mediates RA. These monocyte subsets, -which display specific and distinctive molecular signatures- might promote endothelial dysfunction and in turn, the progression of atherosclerosis through a finely regulated process driving CVD development in RA.

Details

Language :
English
ISSN :
16643224
Volume :
10
Database :
Directory of Open Access Journals
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
edsdoj.17f1bd372f5e4b86852896d605d2bfbc
Document Type :
article
Full Text :
https://doi.org/10.3389/fimmu.2019.01111